Lian Xu Selected Research

Waldenstrom Macroglobulinemia (Macroglobulinemia)

1/2022	Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia.
1/2022	Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy.
1/2022	Venetoclax in Previously Treated Waldenström Macroglobulinemia.
11/2021	The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance.
10/2021	Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
1/2021	Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia.
1/2021	Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia.
6/2020	Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials.
1/2020	A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
1/2020	CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lian Xu Research Topics

Disease

49	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 12/2004
37	Neoplasms (Cancer) 11/2021 - 12/2004
11	Lymphoma (Lymphomas) 02/2022 - 01/2007
8	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2016
7	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2015
6	Carcinoma (Carcinomatosis) 11/2022 - 01/2016
6	Disease Progression 01/2020 - 03/2010
6	Multiple Myeloma 01/2019 - 08/2012
6	Inflammation (Inflammations) 01/2019 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
5	Infections 01/2021 - 10/2004
5	Paraproteinemias (Monoclonal Gammopathy) 03/2016 - 08/2007
4	Necrosis 02/2022 - 08/2007
4	Bone Marrow Diseases (Bone Marrow Disease) 10/2021 - 03/2017
4	Hypertension (High Blood Pressure) 10/2019 - 01/2018
3	Adenocarcinoma 11/2022 - 05/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2018
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 04/2015
3	Lymphatic Metastasis 01/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 01/2019
2	Fibrosis (Cirrhosis) 10/2019 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2018
2	Angiostrongyliasis 01/2019 - 06/2015
2	Ovarian Epithelial Carcinoma 01/2018 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 09/2015
2	Hemorrhage 01/2017 - 04/2015
2	Neutropenia 04/2015 - 07/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009 - 10/2007
2	type 2C Congenital disorder of glycosylation 12/2008 - 05/2006
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Sinusitis 01/2022
1	Parkinson Disease (Parkinson's Disease) 02/2021
1	Abruptio Placentae (Placental Abruption) 07/2020
1	Hemorrhagic Shock 07/2020

Drug/Important Bio-Agent (IBA)

19	ibrutinibIBA 01/2022 - 04/2015
18	Immunoglobulin M (IgM)IBA 10/2021 - 08/2007
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2007
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 01/2020
8	Rituximab (Mabthera)FDA Link 01/2020 - 01/2007
6	Angiotensin IIIBA 10/2019 - 01/2018
5	gallium 68 PSMA-11IBA 01/2022 - 01/2021
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
5	Biological ProductsIBA 01/2019 - 08/2007
5	CytokinesIBA 01/2018 - 10/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2014
4	Bortezomib (Velcade)FDA Link 01/2021 - 08/2007
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2016
4	Monoclonal AntibodiesIBA 01/2016 - 05/2006
4	Immunoglobulin G (IgG)IBA 07/2014 - 01/2007
3	venetoclaxIBA 01/2022 - 07/2015
3	Hemoglobins (Hemoglobin)IBA 10/2021 - 05/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 05/2011
3	Estrogen ReceptorsIBA 01/2020 - 10/2008
3	Long Noncoding RNAIBA 01/2019 - 01/2017
3	LigandsIBA 01/2016 - 08/2007
2	AntigensIBA 01/2022 - 01/2021
2	ElementsIBA 01/2022 - 01/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 10/2008
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
2	ResveratrolIBA 08/2019 - 03/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2018
2	Fibronectins (Fibronectin)IBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2017
2	CollagenIBA 01/2019 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2019 - 02/2011
2	RNA (Ribonucleic Acid)IBA 01/2018 - 02/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 07/2014
2	Therapeutic UsesIBA 01/2018 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 06/2015
2	idelalisibIBA 01/2017 - 07/2015
2	ChemokinesIBA 01/2016 - 06/2015
2	Agammaglobulinaemia Tyrosine KinaseIBA 04/2015 - 08/2013
2	Immunoglobulin A (IgA)IBA 07/2014 - 03/2010
2	Immunoglobulins (Immunoglobulin)IBA 03/2010 - 01/2007
1	MucinsIBA 11/2022
1	Poly(amidoamine)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	FibrinIBA 01/2022
1	Saline SolutionIBA 01/2022
1	Dendrimers (Dendrons)IBA 01/2022
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2022
1	ulocuplumabIBA 10/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2021
1	Probenecid (Benemid)FDA LinkGeneric 02/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	LipidsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Vitamin A (Retinol)FDA LinkGeneric 01/2021
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2007
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2007
2	Castration 01/2022 - 04/2021
2	Salpingo-oophorectomy 07/2020 - 08/2007
1	Oral Administration 11/2021
1	Appendectomy 07/2020
1	Lymph Node Excision (Lymph Node Dissection) 07/2020
1	Hysterectomy 07/2020